Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M608845200 on February 1, 2007

J. Biol. Chem., Vol. 282, Issue 13, 9865-9873, March 30, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/13/9865    most recent
M608845200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rajala, A.
Right arrow Articles by Rajala, R. V. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rajala, A.
Right arrow Articles by Rajala, R. V. S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

G-protein-coupled Receptor Rhodopsin Regulates the Phosphorylation of Retinal Insulin Receptor*

Ammaji Rajala{ddagger}§, Robert E. Anderson{ddagger}§, Jian-Xing Ma||, Janis Lem**, Muayyad R. Al-Ubaidi, and Raju V. S. Rajala, Recipient of a Career Development Award from Research to Prevent Blindness, Inc{ddagger}§1

From the Departments of {ddagger}Ophthalmology, Cell Biology, and ||Medicine and the §Dean A. McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104 and the **Department of Ophthalmology, New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111

Received for publication, September 13, 2006 , and in revised form, January 9, 2007.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
We have shown previously that phosphoinositide 3-kinase in the retina is activated in vivo through light-induced tyrosine phosphorylation of the insulin receptor (IR). The light effect is localized to photoreceptor neurons and is independent of insulin secretion (Rajala, R. V., McClellan, M. E., Ash, J. D., and Anderson, R. E. (2002) J. Biol. Chem. 277, 43319–43326). These results suggest that there exists a cross-talk between phototransduction and other signal transduction pathways. In this study, we examined the stage of phototransduction that is coupled to the activation of the IR. We studied IR phosphorylation in mice lacking the rod-specific {alpha}-subunit of transducin to determine if phototransduction events are required for IR activation. To confirm that light-induced tyrosine phosphorylation of the IR is signaled through bleachable rhodopsin, we examined IR activation in retinas from RPE65-/- mice that are deficient in opsin chromophore. We observed that IR phosphorylation requires the photobleaching of rhodopsin but not transducin signaling. To determine whether the light-dependent activation of IR is mediated through the rod or cone transduction pathway, we studied the IR activation in mice lacking opsin, a mouse model of pure cone function. No light-dependent activation of the IR was found in the retinas of these mice. We provide evidence for the existence of a light-mediated IR pathway in the retina that is different from the known insulin-mediated pathway in nonneuronal tissues. These results suggest that IR phosphorylation in rod photoreceptors is signaled through the G-protein-coupled receptor rhodopsin. This is the first study demonstrating that rhodopsin can initiate signaling pathway(s) in addition to its classical phototransduction.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Insulin receptor (IR)2 activation has been shown to rescue retinal neurons from apoptosis through a phosphoinositide 3-kinase (PI3K) cascade (1). Particular insights have come from observations that IR substrate-2 (principle substrate of the IR) knock-out mice lose up to 50% of their photoreceptors by 2 weeks of age, due to increased apoptosis (2). Very recently, we have shown that Ak2, another downstream target of the IR, is essential for photoreceptor survival and maintenance, since ablation of this protein in the retina resulted in stress-induced retinal degeneration (3). Specific deletion of bcl-xl (down-stream effector of Akt) from rod photoreceptor cells also results in stress-induced retinal degeneration (4). These studies clearly suggest that the IR pathway is important for photoreceptor survival and maintenance.

Many retinal degenerative diseases show an early loss of rod cells that is followed by loss of cone cells, and the pathological phenotype for this loss is apoptosis (5–7). The induction of cell death is a highly regulated process and can be suppressed by a variety of extracellular signals (8, 9). The ability of trophic factors to promote survival is mediated, at least in part, by PI3K (1, 10–12). Activation of PI3K is a critical step in signal transduction pathways triggered by a variety of extracellular stimuli (13). The lipid products of PI3K serve as second messengers to recruit specific phospholipid-binding proteins to the plasma membrane and control the activity and subcellular localization of a diverse array of signal transduction molecules (14).

In Drosophila, the IR serves an important function in guiding the development of retinal photoreceptor axons from the retina to the brain (15). The IR also influences the size and number of photoreceptors in Drosophila (16). In Caenorhabditis elegans, the IR regulates neuronal survival (17). The high degree of IR signaling homology among C. elegans, Drosophila, and humans suggests functional conservation of the IR in the mammalian retina. In humans, defects in IR signaling in the central nervous system are associated with Alzheimer disease (18–20). The lack of IR activation leads to neurodegeneration in the brain/neuron-specific IR knock-out mice (21).

The retina expresses PI3K, which is regulated through the light-induced tyrosine phosphorylation of the IR in vivo (22, 23). Light-induced activation of the retinal IR is independent of insulin secretion, and the light effect is localized to photoreceptor neurons (22). These results suggest that there exists a cross-talk between phototransduction and other signal transduction pathways. To dissect the stage of the phototransduction cascade that is coupled to the activation of the IR, we examined IR phosphorylation in three knock-out mouse models that are deficient in either phototransduction or the ability to form functional rhodopsin. In the present study, we demonstrate that light-induced tyrosine phosphorylation of the IR requires the photobleaching of rhodopsin but not transducin signaling. We also show that the light-dependent IR activation occurs in rod, but not in cone, photoreceptors. These studies suggest that rhodopsin can cross-talk with other signaling pathways in addition to the classical phototransduction cascade.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Materials—Polyclonal anti-Glut1, anti-IRbeta, and monoclonal anti-PY-99 antibodies were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Polyclonal anti-insulin/IGF-1-like growth factor-1 receptor (Tyr(P)1158/Tyr(P)1162/Tyr(P)1163) phosphospecific antibody was obtained from BIOSOURCE (Camarillo, CA). The monoclonal anti-opsin antibody (Rho 4D2) was a gift from Dr. Robert Molday (University of British Columbia). Human insulin R (rDNA origin) was obtained from Lilly. [{gamma}-32P]ATP was from PerkinElmer Life Sciences. Anti-GST antibody was from Amersham Biosciences. Echelon Research laboratories Inc. (Salt Lake City, UT) provided D-myo-phosphatidylinositol-4,5-bisphosphate (PI-4,5-P2). Wheat germ agglutinin (WGA)-Sepharose 4B beads were from Vector Laboratories (Burlingame, CA). All other reagents were of analytical grade from Sigma.

Animals—All animal work was in strict accordance with Ref. 78 and the Association for Research in Vision and Ophthalmology resolution on the use of animals in vision research. All protocols were approved by the institutional animal care and use committee of the University of Oklahoma Health Sciences Center and the Dean McGee Eye Institute. Transducin {alpha} subunit knock-out (Tr{alpha}-/-) mice (24) and opsin knock-out mice (25) were derived on a BALB/cx129/SvJ background at Tufts University. Mice lacking retinal pigment epithelium 65 (RPE65-/-) were derived at the National Institutes of Health (Bethesda, MD) (26). Wild-type controls were obtained from breeding pairs established with C57BL/6-DBA F1s. A breeding colony of albino Sprague-Dawley rats is maintained in our vivarium in cyclic light (5 lux; 12 h on/12 h off). Experiments were carried out on both male and female rats (150–200 g).

Retinal Organ Cultures—Retinas were removed from Sprague-Dawley albino rats that were born and raised in dim cyclic light (5 lux; 12 h on/12 h off) and incubated at 37 °C in Dulbecco's modified Eagle's medium (Invitrogen) in the presence or absence of 1 µM insulin for 30 min. At the indicated times, retinas were snap-frozen in liquid nitrogen and stored at -80 °C until analyzed. The retinas were lysed in lysis buffer (1% Nonidet P-40, 20 mM HEPES (pH 7.4), and 2 mM EDTA) containing phosphatase inhibitors (100 mM NaF, 10 mM Na4P2O7, 1 mM NaVO3, and 1 mM molybdate) and protease inhibitors (10 µM leupeptin, 10 µg/ml aprotinin, and 1 mM PMSF) and kept on ice for 10 min followed by centrifugation at 4 °C for 20 min.

PI3K Assay—Enzyme assays were carried out as previously described (27). Briefly, assays were performed directly on IRbeta immunoprecipitates of retinal lysates or rod outer segments (ROS) prepared from light- and dark-adapted retinas in 50 µl of reaction mixture containing 0.2 mg/ml PI-4,5-P2, 50 µM ATP, 10 µCi of [{gamma}-32P]ATP, 5 mM MgCl2, and 10 mM HEPES buffer (pH 7.5). The reactions were carried out for 30 min at room temperature and stopped by the addition of 100 µl of 1 N HCl followed by 200 µl of chloroform/methanol (1/1, v/v). Lipids were extracted and resolved on oxalate-coated TLC plates (silica gel 60) with a solvent system of 2-propanol, 2 M acetic acid (65/35, v/v). The plates were coated in 1% (w/v) potassium oxalate in 50% (v/v) methanol and then baked in an oven at 100 °C for 1 h prior to use. TLC plates were exposed to x-ray film overnight at -70 °C, and radioactive lipids were scraped and quantified by liquid scintillation counting.

GST Pull-down Experiments—Pull-down experiments were carried out as described (28) using 5 µg of GST-fusion proteins that had been adsorbed onto GST-Sepharose 4B matrix. Retina lysates (insulin-treated or untreated in vitro) or light- and dark-adapted retina lysates were incubated with GST/GST-p85 (N-SH2) fusion proteins (29) at 4 °C for 1.5 h with continuous mixing. The Sepharose beads were washed three times in 500 µl of wash buffer (50 mM HEPES (pH 7.4) containing 118 mM NaCl, 100 mM NaF, 2 mM NaVO3, 0.1% (w/v) SDS, and 1% (v/v) Triton X-100) and centrifuged at 5,000 rpm for 30–60 s at 4 °C. Bound proteins were eluted by boiling in 2x SDS sample buffer 5 min prior to 10% SDS-PAGE. After SDS-PAGE, the gels were subjected to Western blot analysis with anti-IRbeta antibody. To ensure an equal amount of fusion protein in each experiment, the blot was stripped and reprobed with anti-GST antibody.

Preparation of Osmotically Intact Rod Outer Segment Disks— Osmotically intact rod outer segment disks were prepared by Ficoll flotation (30). The ROS were prepared from frozen bovine retinas according to the method described (31). The ROS pellet was resuspended in 30 ml of Ficoll in distilled water, and the suspension was kept at 4% under nitrogen for at least 2 h to allow the ROS plasma membrane to burst. This suspension of ROS was divided between two small SW-28 centrifuge tubes and layered with cold water. After 2 h of centrifugation in a SW-20 rotor at 25,000 rpm, the intact disks were collected from 5% Ficoll water interface. The bottom pellet contained the ROS plasma membrane-enriched fraction.

Preparation of Sealed Bovine Rod Cell Outer Segments—ROS were prepared from bovine retinas on a continuous sucrose gradient (25–50%, w/v) as described (32). Dark-adapted ROS were prepared under dim red light from dark-adapted retinas. Bleached ROS were prepared by exposing dark-adapted retinas to room light (ceiling fluorescent bulbs, 700 lux) for 30 min at room temperature before preparation of ROS. Protein quantification was performed with BCA reagent (Pierce) following the manufacturer's instructions.

Preparation of Rat Rod Outer Segments—ROS were prepared from rat retinas using a discontinuous sucrose gradient as previously described (22). Retinas were homogenized in 4.0 ml of ice-cold 47% sucrose solution containing 100 mM NaCl, 1 mM EDTA, 1 mM NaVO3, 1 mM PMSF, and 10 mM Tris-HCl (pH 7.4) (buffer A). Retinal homogenates were transferred to 15-ml centrifuge tubes and sequentially overlaid with 3.0 ml of 42%, 3.0 ml of 37%, and 4.0 ml of 32% sucrose dissolved in buffer A. The gradients were spun at 82,000 x g for 1 h at 4°C. The 32/37% interfacial sucrose band containing ROS membranes was harvested and diluted with 10 mM Tris-HCl (pH 7.4) containing 100 mM NaCl and 1 mM EDTA and centrifuged at 27,000 x g for 30 min. The ROS pellets were resuspended in 10 mM Tris-HCl (pH 7.4) containing 100 mM NaCl and 1 mM EDTA and stored at -20 °C. All protein concentrations were determined by the BCA reagent following the manufacturer's instructions.

Immunoprecipitation—ROS membranes were solubilized for 30 min at 4 °C in a lysis buffer (1% Nonidet P-40, 20 mM HEPES (pH 7.4), and 2 mM EDTA) containing phosphatase inhibitors (100 mM NaF, 10 mM Na4P2O7, 1 mM NaVO3, and 1 mM molybdate) and protease inhibitors (10 µM leupeptin, 10 µg/ml aprotinin, and 1 mM PMSF) and kept on ice for 10 min. Insoluble material was removed by centrifugation at 17,000 x g for 20 min at 4 °C. Either ROS or retina lysates were precleared by incubation with 40 µl of protein A-Sepharose for 1 h at 4°C with mixing. The supernatant was incubated with anti-IRbeta (4 µg) antibody overnight at 4 °C and subsequently with 40 µl of protein A-Sepharose for 2 h at 4 °C. Following centrifugation at 14,000 rpm for 1 min, immune complexes were washed three times with wash buffer (50 mM HEPES (pH 7.4) containing 118 mM NaCl, 100 mM NaF, 2 M NaVO3, 0.1% (w/v) SDS, and 1% (v/v) Triton X-100). Immunoprecipitates were subjected to either immunoblot analysis with anti-PY-99 (1:1000), anti-IR (Tyr(P)1158/Tyr(P)1162/Tyr(P)1163) (1:1000), anti-opsin (1:10,000), or anti-IRbeta (1:1000) antibodies, or measured directly for PI3K activity.

SDS-PAGE and Western Blotting—Proteins were resolved by 10% SDS-PAGE and transferred onto nitrocellulose membranes. The blots were washed two times for 10 min with TTBS (20 mM Tris-HCl (pH 7.4), 100 mM NaCl, and 0.1% Tween 20) and blocked with either 5% bovine serum albumin or nonfat dry milk powder (Bio-Rad) in TTBS for 1 h at room temperature. Blots were then incubated with anti-IRbeta (1:1000), anti-PY-99 (1:1000), anti-Glut1 (1:1000), anti-IR (Tyr(P)1158/Tyr(P)1162/Tyr(P)1163) (1:1000), anti-opsin (1:10,000), or anti-GST (1:5000) antibodies overnight at 4 °C. Following primary antibody incubations, immunoblots were incubated with HRP-linked secondary antibodies (either anti-rabbit or anti-mouse) and developed by ECL according to the manufacturer's instructions. Densitometric analysis of immunoblots where indicated was performed using Kodak Image Station 4000R (Eastman Kodak Co.) in the linear range of detection. Absolute values were then normalized to total protein as indicated in the figure legends.

Statistical Methods—The data were expressed as the mean ± S.D. and compared by Student's t test for unpaired data. The critical level of significance was set at p < 0.05.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
IRs Are Localized to Plasma Membrane—Bovine crude rod outer segments were subjected to Ficoll gradient centrifugation to isolate ROS disks (30). ROS, plasma membrane, and isolated disks were subjected to Western blot analysis with anti-IRbeta, anti-Glut1, and anti-opsin antibodies. The results indicate that IR, Glut1, and opsin immunoreactivity was present in the ROS (Fig. 1). IR and the plasma membrane marker Glut1 immunoreactivity was enriched in the plasma membrane fraction of the ROS (Fig. 1). Opsin blots show the enrichment of opsin in the disk membranes (Fig. 1). These results suggest that IRs are localized to the plasma membrane.


Figure 1
View larger version (63K):
[in this window]
[in a new window]

  		FIGURE 1.
IR localization to the plasma membrane. Bovine ROS, plasma membrane (PM), and disk (Disk) proteins were subjected to Western blot analysis with anti-IRbeta, anti-Glut1, and anti-opsin antibodies.

 
Light-induced Activation of PI3K in Isolated Rod Outer Segments—We examined the light activation of the IR by immunoprecipitating it and measuring the associated PI3K activity (22). ROS prepared from dark-adapted bovine retinas were solubilized with 1% Triton X-100 followed by incubation with WGA-Sepharose 4B matrix, since WGA is known to interact with IRs (33). The unbound proteins were washed away and PI3K activity associated with WGA was measured. The results indicate a higher PI3K activity associated with bleached ROS (BROS) compared with dark-adapted ROS (DROS) (Fig. 2A), suggesting that light could activate the IR in vitro.

Insulin-induced Activation of PI3K in Isolated Rod Outer Segments—To test the effect of insulin on PI3K activity, bovine ROS isolated on continuous sucrose density gradients were incubated either in the presence or absence of 1 µM insulin for 30 min at room temperature. Following incubation, bovine ROS were solubilized with 1% Triton X-100 and then immunoprecipitated with anti-IRbeta antibody, followed by measurement of the PI3K activity associated with anti-IRbeta immunoprecipitates. The results indicate increased PI3K activity associated with insulin-stimulated bovine ROS (Fig. 2B) and suggest that functional IR is present in ROS.

Light Activation of the Retinal IR in Vivo—To determine if light has an effect on PI3K activity and phosphorylation of the IR, rats were dark-adapted overnight, and half were exposed to normal room light for 30 min. Retinas were quickly removed and homogenized, the lysates were subjected to ROS preparation or immunoprecipitated with anti-IRbeta antibody, and PI3K activity was measured. ROS membranes that were prepared on discontinuous sucrose gradients showed greater PI3K activity in light-adapted rats compared with dark-adapted rats (Fig. 3, A and B). When retinal homogenates were immunoprecipitated with anti-IRbeta antibody, PI3K activity was higher in immunoprecipitates from light-adapted compared with from dark-adapted rat retinas (Fig. 3, C and D). Collectively, these experiments suggest that the PI3K activity associated with the ROS membranes is activated through the IR.

Activation of IR by Insulin in Organ Cultures—The organ culture system has been successfully used to study protein phosphorylation and provides access to the retina for the addition of exogenous modulators of cellular function (29). IR phosphorylation was confirmed in anti-IRbeta immunoprecipitates of insulin-treated and untreated retinas by probing lysates with anti-phosphotyrosine (PY-99) antibody. Increased phosphorylation was observed on Western blots of anti-IRbeta insulin-treated immunoprecipitates, demonstrating the phosphorylation of IRbeta in response to insulin (Fig. 4A). To ensure equal amounts of IRbeta in immunoprecipitates, PY-99 blots were stripped and reprobed with anti-IRbeta antibody (Fig. 4B). Higher PI3K activities were observed in the anti-IRbeta immunoprecipitates of insulin-stimulated retinas (Fig. 4, C and D). These results further suggest that retinal IRs are functional and are sensitive to both light (Fig. 2) and insulin (Fig. 3).


Figure 2
View larger version (77K):
[in this window]
[in a new window]

  		FIGURE 2.
Light- and insulin-induced activation of PI3K in isolated ROS. Dark-adapted and bleached ROS (500 µg) were incubated with WGA-Sepharose 4B. PI3K activity associated with WGA-Sepharose was measured using PI-4,5-P2 and [{gamma}-32P]ATP as substrates (A). Bovine ROS were treated with either the presence or absence of 1 µM insulin and subjected to immunoprecipitation with anti-IRbeta antibody. PI3K activity associated with anti-IRbeta immunoprecipitates were measured using PI-4,5-P2 and [{gamma}-32P] ATP as substrates (B). DROS, dark-adapted ROS; BROS, bleached ROS.

 


Figure 3
View larger version (40K):
[in this window]
[in a new window]

  		FIGURE 3.
Effect of light on PI3K activity. PI3K activity was measured in ROS prepared from light- and dark-adapted rat retinas (A) and anti-IRbeta immunoprecipitates of lysates from light- and dark-adapted retinas (C). PI3K activity was measured using PI-4,5-P2 and [{gamma}-32P]ATP as substrate. The radioactive spots of phosphatidylinositol-3,4,5-trisphosphate (PI-3,4,5-P3) were scraped from TLC plates and counted (B and D). LROS, light-adapted ROS; DROS, dark-adapted ROS. Data are mean ± S.D., n = 6, *, p < 0.05.

 


Figure 4
View larger version (32K):
[in this window]
[in a new window]

  		FIGURE 4.
Activation of the IR by insulin in organ cultures. Rat retinas were stimulated with 1 µM insulin in organ cultures, lysed, and subjected to either immunoprecipitation or GST pull-down assays. Retinal lysates were immunoprecipitated with anti-IRbeta antibody followed by Western blot analysis with anti-PY-99 antibody (A). The blot was stripped and reprobed with anti-IRbeta antibody to ensure an equal amount of protein in each immunoprecipitation (B). PI3K activity was measured in anti-IRbeta immunoprecipitates of insulinstimulated and unstimulated retinas using PI-4,5-P2 and [{gamma}32P]ATP as substrates (C). The radioactive spots of phosphatidylinositol-3,4,5-trisphosphate (PI-3,4,5-P3) were scraped from TLC plates and counted (D). Data are mean ± S.D., n = 6. *, p < 0.05. Insulin-stimulated and unstimulated retina lysates were subjected to GST pull-down assay (125 µg) with GST-p85 (N-SH2) fusion protein followed by Western blot analysis of the bound proteins with anti-IRbeta antibody (E). The blot was stripped and reprobed with anti-GST (F) to ensure an equal amount of fusion in each pull-down.

 


Figure 5
View larger version (39K):
[in this window]
[in a new window]

  		FIGURE 5.
Light-dependent phosphorylation of IR in Tr{alpha}-/- mice. Lysates of retina from dark- and light-adapted Tr{alpha}-/- mice were subjected to GST pull-down assays with GST-p85 (N-SH2) domain. Bound proteins were probed with anti-IRbeta antibody (A). To ensure equal protein in both light and dark conditions, the original lysates were probed with anti-opsin (B) and anti-GST antibodies (C). L, light; D, dark; P-IR, phosphorylated IR.

 
Binding of IRbeta to the p85 (N-SH2) Domain of PI3K—The addition of insulin to the retinal organ cultures resulted in activation of the IR as measured by receptor phosphorylation in a GST pull-down assay (29). The GST p85 (N-SH2) domain specifically pulled down the phosphorylated form of the IR (22, 34). In the presence of insulin, the p85 (N-SH2) domain of PI3K could pull down IRbeta as detected on the Western blots probed with anti-IRbeta antibody (Fig. 4E). To ensure equal amounts of fusion proteins in each pull-down, IRbeta blots were stripped and reprobed with anti-GST antibody (Fig. 4F). These results suggest that the p85 subunit of PI3K specifically recognizes the phosphorylated form of the IR.

The Visual Transduction Cascade and IR Phosphorylation—We examined IR phosphorylation in mice lacking transducin (Tr{alpha}-/-) to determine if phototransduction events are required for IR phosphorylation. Tr{alpha}-/- mice were dark-adapted overnight, and half were exposed to normal room light for 30 min. Retinal lysates from light- and dark-adapted Tr{alpha}-/- mice were subjected to GST pull-down assays using the p85 (N-SH2) domain followed by Western blot analysis with anti-IRbeta antibody. The results indicate that Tr{alpha}-/- mice still exhibit a light-dependent phosphorylation of IR (Fig. 5A). The proteins were normalized based on the opsin content, which was used as an internal control (Fig. 5B). To ensure equal amounts of fusion in each pull-down, IRbeta blots were stripped and reprobed with anti-GST antibody (Fig. 5C). These results suggest that the visual transduction cascade is not necessary for light-dependent IR phosphorylation.


Figure 6
View larger version (53K):
[in this window]
[in a new window]

  		FIGURE 6.
Absence of IR phosphorylation in RPE65-/- mice. Dark- and light-adapted RPE65-/- mouse retinas were lysed and subjected to GST pull-down assays with GST-p85 (N-SH2) domain. The bound proteins were subjected to Western blot analysis with anti-IRbeta antibody (A). Immunoblot with anti-IRbeta (B), anti-opsin (C), and anti-GST (D) blot demonstrated equal protein in each lysate. Wild-type retina stimulated with insulin was used as positive control (A). L, light; D, dark; P-IR, phosphorylated IR.

 


Figure 7
View larger version (44K):
[in this window]
[in a new window]

  		FIGURE 7.
Insulin-induced activation of the IR in RPE65-/- mouse retinas. RPE65-/- mouse retinas were stimulated with 1 µM insulin in organ cultures, lysed, and subjected to GST pull-down assay with GST-p85 (N-SH2) domain. The bound proteins were subjected to Western blot analysis with anti-IRbeta antibody (A). Immunoblots with anti-IRbeta (B), anti-opsin (C), and anti-GST (D) antibodies demonstrated equal protein in each lysate. Wild type (WT) retinas stimulated with insulin were used as a positive control (A). P-IR, phosphorylated IR.

 
Photobleaching of Rhodopsin and IR Phosphorylation—To confirm that the light-induced IR phosphorylation is signaled through rhodopsin, we examined the phosphorylation of the IR in retinas from retinal pigment epithelium protein (RPE65) knock-out mice that are deficient in 11-cis-retinal, the chromophore for rhodopsin (26). These animals have opsin in their ROS but do not have a bleachable rhodopsin due to the absence of the chromophore. RPE65-/- mice were dark-adapted overnight, and half were exposed to normal room light for 30 min. Retinal lysates from light- and dark-adapted RPE65-/- mice were subjected to GST pull-down assays using the p85 (N-SH2) domain, followed by Western blot analysis with anti-IRbeta antibody. The results indicate the absence of light-induced IR phosphorylation in RPE65-/- mice (Fig. 6A). IR was recovered from retinal lysates stimulated with insulin in vitro (Fig. 6A, Control). Total IR content was examined with anti-IRbeta antibody (Fig. 6B). The proteins were normalized based on the opsin content, which was used as an internal control (Fig. 6C). To ensure equal amount of fusion in each pull-down, the IRbeta blot was stripped and reprobed with anti-GST antibody (Fig. 6D). These results suggest that photobleaching of rhodopsin is necessary for IR phosphorylation.

Insulin Activation of IR Phosphorylation in RPE65-/- Mice— RPE65-/- mouse retinas were stimulated with 1 µM insulin in organ cultures, after which the retinas were lysed and subjected to GST pull-down assays using the p85 (N-SH2) domain followed by Western blot analysis with anti-IRbeta antibody. The results indicate the IR can be phosphorylated in response to insulin stimulation in RPE65-/- retinas (Fig. 7A). Total IR content was examined with anti-IRbeta antibody (Fig. 7B). The proteins were normalized based on the opsin content, which was used as an internal control (Fig. 7C). To ensure an equal amount of fusion in each pull-down, the IRbeta blot was stripped and reprobed with anti-GST antibody (Fig. 7D). These results indicate the existence of a light-mediated IR pathway in the retina that is different from the known insulin-mediated pathway in non-neuronal tissues. Collectively, these experiments show that photobleaching of rhodopsin is necessary for light-mediated phosphorylation of the IR.


Figure 8
View larger version (42K):
[in this window]
[in a new window]

  		FIGURE 8.
Light activation of tyrosine phosphorylation in the catalytic loop of the IR. Two hundred micrograms of protein were immunoprecipitated with anti-IRbeta antibody from either mouse retina lysates (A) or ROS (C) prepared from light- and dark-adapted rats. The immunoprecipitates were subjected to Western blot analysis with anti-IR (Tyr(P)1158/Tyr(P)1162/Tyr(P)1163) antibody. The blots were stripped and reprobed with anti-IRbeta antibody to ensure equal amount of protein in each lane (B and D). The experiment was carried out on retina lysates from three independent sets for light and dark adaptation. The ROS experiment was carried out on two independent sets of light- and dark-adapted retinas. Each set had 24 rats (12 animals for light and 12 animals for dark adaptation). L, light; D, dark; LROS, light-adapted ROS; DROS, dark-adapted ROS.

 
Light Activation of Tyrosine Phosphorylation in the Catalytic Loop of the IR—The catalytic loops within the tyrosine kinase domain of the IR contain a three-tyrosine (Tyr1158, Tyr1162, and Tyr1163) motif (35, 36). It is generally believed that autophosphorylation within the activation loop proceeds in a processive manner initiated at the second tyrosine (position 1162), followed by phosphorylation at the first tyrosine (position 1158), and finally the last (position 1163), upon which the IR becomes fully active (35, 36). To determine whether light activates IR in the same manner as insulin, we immunoprecipitated the IR (Fig. 8) from retinal lysates that were prepared from light- and dark-adapted mice followed by Western blot analysis with phosphospecific anti-IR (Tyr(P)1158/Tyr(P)1162/Tyr(P)1163) antibody. The results indicate an increased phosphorylation in the light-adapted retinas compared with dark-adapted retinas (Fig. 8A). The blot was stripped and reprobed with anti-IRbeta antibody to ensure an equal amount of protein in each line (Fig. 8B). LROS and DROS were solubilized with 1% Nonidet P-40, and the IR was immunoprecipitated followed by Western blot analysis with anti-IR (Tyr(P)1158/Tyr(P)1162/Tyr(P)1163) antibody. The results indicate the tyrosine phosphorylation in LROS (Fig. 8C). The blot was stripped and reprobed with anti-IRbeta antibody to ensure an equal amount of protein in each line (Fig. 8D). These results suggest that light activates the IR phosphorylation in the catalytic loop within the tyrosine kinase domain.

Activation of IR Signaling through Light Stimulation of Rods—To determine whether the activation of the IR is signaled through light stimulation of rods, we examined the phosphorylation of the IR in retina lysates from opsin-/- mice. Although these mice have the full complement of rod photoreceptor cells, they lack rod outer segments and scotopic electroretinographic signal (25). However, retinas of opsin-/- mice exhibit normal photopic electroretinographic responses reflecting the existence of functional cone transduction pathways (25, 37). Therefore, these mice afforded the ideal system to test the activation of IR signaling through light stimulation of rods and to determine if any contributions are made by cones. To that end, C57Bl/6 control, heterozygous opsin+/-, and homozygous opsin-/- mice were dark-adapted overnight; half were exposed to normal room light for 30 min, and the rest were kept in the dark. Retinal lysates from light- and dark-adapted mice from the three groups were subjected to immunoprecipitation with anti-IRbeta antibody followed by Western blot analysis with anti-IR (Tyr(P)1158/Tyr(P)1162/Tyr(P)1163) antibody. The blots were stripped and reprobed with anti-IRbeta antibody. Densities were calculated from the respective immunoblots, and the results are expressed as phospho-IR/total IR. In control mice, we observed a significant increase in the IR phosphorylation from light-adapted retinas compared with dark-adapted retinas (Fig. 9A). In heterozygous opsin+/- mice, the IR phosphorylation was higher but not statistically significant in light-adapted retinas compared with dark-adapted retinas (Fig. 9B), whereas in homozygous opsin-/- mice, the light-dependent activation of the IR was lost (Fig. 9C). These results suggest that the light-dependent activation of the IR may be regulated through the rod transduction pathway but not the cone transduction pathway.


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
The experiments reported here show that IR phosphorylation requires the photobleaching of rhodopsin but does not require transducin signaling. These results also suggest that components downstream of transducin (PDE, Ca2+, cGMP, etc.) are not required for IR phosphorylation. Consistent with this idea, it has been shown that there is no difference in dark [Ca2+] between wild type and Tr{alpha}-/- mice (38). The Rpe65-/- retinas fail to photobleach due to the absence of 11-cis-retinal (26), and thus retinal IR phosphorylation by light does not occur in these animals. However, stimulation of RPE65-/- retinas with insulin results in the phosphorylation of the IR. These experiments clearly show the existence of a light-mediated IR pathway in the retina, which is different from the known insulin-mediated pathway in nonneuronal tissues. Our results also suggest that a cross-talk exists between phototransduction and other signal transduction pathways. This cross-talk phenomenon has been shown for other G-protein-coupled receptors (GPCRs), and many tyrosine kinase cascades are regulated by GPCRs (39, 40). Examples include mitogen-activated protein kinase cascade, extracellular-regulated kinases, and stress-activated protein kinases (40). Further, the binding of PYK2, a non-receptor protein-tyrosine kinase, to N-terminal domain-interacting receptors (Nir) is activated by GPCRs (41). The Nir proteins are the human homologs of the Drosophila retinal degeneration B protein (RdgB), a protein implicated in the visual transduction pathway in flies (41). These earlier studies along with the present study clearly suggest that photobleaching of rhodopsin may activate more than one signaling pathway.

Several studies have shown that retinal ROS contain intrinsic tyrosine kinase(s) that can be activated by light (42) to phosphorylate several ROS proteins (43, 44). It has been shown that light exposure in vivo activates Src and promotes its association with a complex containing bleached rhodopsin and arrestin (45). Retinal BIT (brain immunoglobulin-like molecules with a tyrosine-based activation motif) protein has been shown to be tyrosine-phosphorylated in vitro in a light-dependent manner (46). Evidence also indicates that the small G-protein Rac-1 may be regulated by rhodopsin in both Drosophila (47) and vertebrates (48). The {alpha}-subunit of the heterotrimeric G-protein, G11{alpha}, does not participate in visual transduction, but the opsin-G11-mediated signaling pathway is important for photic entrainment of the chicken pineal circadian clock (49). These studies clearly suggest that signaling proteins not directly involved in phototransduction could be activated upon illumination. The molecular mechanism behind the light activation of signaling proteins other than those involved in phototransduction (50–58) is not known.


Figure 9
View larger version (10K):
[in this window]
[in a new window]

  		FIGURE 9.
Activation of the IR through light stimulation of rods. Two hundred micrograms of protein were immunoprecipitated with anti-IRbeta antibody from retina lysates from light- and dark-adapted control (A), heterozygous opsin+/- (B), and homozygous opsin-/- (C) mice. The immunoprecipitates were subjected to Western blot analysis with anti-IR (Tyr(P)1158/Tyr(P)1162/Tyr(P)1163) antibody. The blots were stripped and reprobed with anti-IRbeta antibody to ensure an equal amount of protein in each lane. Densities were calculated from the immunoblots, and the results are expressed as phospho-IR/total IR. Data are mean ± S.D., n = 6. *, p < 0.05.

 
Although no GTP-binding protein can substitute for transducin-mediated phototransduction in vertebrate rods (24), other G-proteins, such as G{alpha}q and G{alpha}11, appear to be present (59) and may be coupled to rhodopsin for other functions (49). IR phosphorylation in other G-protein knock-out/double knock-out (Tr{alpha} and G{alpha}q or G{alpha}11) mouse models would give information about the importance of other G-proteins in signaling the IR.

The light-dependent IR phosphorylation in Tr{alpha}-/- mice could also be due to cone transducin. We addressed this issue using opsin-/- mice; these mice do not have rod function and are used to study pure cone function (25, 37). Opsin gene disruption has been shown to affect the rod morphology and development (25). At 15 days, opsin-/- retinas contained a normal number of rod nuclei with inner segments, but outer segments failed to develop (25). By 30 days, 10–15% and at 90 days, over 90% of rod nuclei are lost in these mice (25). We carried out our experiments in 3-week-old mice whose retinas still showed the presence of photoreceptor-specific proteins, such as transducin and arrestin (data not shown). We clearly showed that a light-dependent IR activation in these mice is absent, whereas light-dependent activation in wild type and heterozygote mice from the same litters was clearly observed. The results are almost identical to our previous studies on RD1 mutant mice, which also failed to activate the IR in the absence of photoreceptors (22). If cone transducin signals are involved, we would expect to see some light-dependent activation of the IR. Since none was found in these retinas, we conclude that the phenomenon we are describing occurs in rod photoreceptors. However, it may be possible that the light-dependent activation of the IR also occurs in cones but that the signal cannot be measured in rodent retinas, which contain very small numbers of cones relative to rods. The IR phosphorylation appears to be higher in heterozygous opsin+/- mice, but the activation is not statistically significant between light- and dark-adapted retinas. The opsin content in the heterozygous mice has ~50% of the normal amount of rhodopsin, and these mice are ~50% less sensitive to light (25). It is tempting to speculate that full complementation of the IR activation might require >50% opsin.

The molecular mechanism behind the light-induced activation of the IR is not known. In this study, we observed the recognition of light-induced autophosphorylation/phosphorylation of IR by phosphospecific IR antibody, which specially recognizes the tyrosine phosphorylation in the catalytic loop of IR at tyrosines 1158, 1162, and 1163 (35, 36). These results suggest that light activates the tyrosine phosphorylation in the catalytic loop of IR.


Figure 10
View larger version (37K):
[in this window]
[in a new window]

  		FIGURE 10.
Working model of light-induced activation of the IR. Grb14, an upstream regulator of IR (IR), requires photobleaching of rhodopsin for membrane targeting. Grb14 protects the IR phosphorylation against PTP1b. Our hypothesis is that a light signal initiates the localization of Grb14 to photoreceptor outer segment membranes, which protects IR from dephosphorylation by PTP1b. Light-activated IR is subsequently associated with PI3K, a cell survival factor, and thus regulates the downstream survival pathway.

 
It appears from our study that two types of IR activities exist in the retina, one activated through the photobleaching of rhodopsin and the other activated through ligands, such as insulin or IGF1 (60, 61). It has been shown previously that basal IR kinase activity in the retina was significantly greater than that of liver and remained constant between freely fed and fasted rats, suggesting that IR activation was not regulated by circulating insulin (60, 62). We have previously reported that light-induced tyrosine phosphorylation of the retinal IR is independent of insulin secretion (22). Our studies showing the localization of IR to the plasma membrane suggest that there must be soluble factor(s) connecting photobleaching of rhodopsin to the phosphorylation status of IR.

Consistent with this hypothesis, we have identified Grb14 (growth factor receptor-bound protein 14) as an IR-interacting protein (63, 64), and its intracellular localization is light-dependent (65). The Grb14 is a known inhibitor of protein-tyrosine phosphatase, PTP1b (66–69). We have also recently reported the expression of PTP1b in rod outer segments (64), and its levels are unchanged under light and dark adaptation.3 Based on these studies, we propose a working model (Fig. 10) in which the retinal IR autophosphorylates constitutively (60). In dark-adapted ROS, the IR is maintained in an inactive state by rapid dephosphorylation by PTP1b. Light activation of rhodopsin initiates the localization of Grb14 to ROS membranes, where it prevents the IR dephosphorylation by PTP1b. Light-activated IR subsequently associates with PI3K, a cell survival factor, activating the downstream survival pathway.

The IR pathway is known to be implicated both in neuroprotection of the retina (70) and in diabetic retinopathy (61). The functional consequences of light-dependent activation of the IR in photoreceptor cells are unknown. Activation of the IR signaling pathway has been shown to have complex physiological roles in a variety of cell types (71). In rods, IR activity is regulated by light, which suggests that its function could be related to rod-specific activities that are driven by light, such as shedding of photoreceptor tips (72), biogenesis of new ROS membranes through the addition of newly synthesized membranes at the base of the ROS (73), or light adaptation (74). Light activation could also initiate neuroprotective pathways (75–77). Further studies are required to understand the role of light-induced activation of IR in photoreceptor functions.


   FOOTNOTES
 
* This work was supported by National Institutes of Health Grants EY016507, EY00871, EY04149, EY12190, and RR17703 and grants from Research to Prevent Blindness Inc. and the Foundation Fighting Blindness, Inc. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 To whom correspondence should be addressed: University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd., Oklahoma City, OK 73104. Tel.: 405-271-8255; Fax: 405-271-8128; E-mail: raju-rajala{at}ouhsc.edu.

2 The abbreviations used are: IR, insulin receptor; PI3K, phosphoinositide 3-kinase; GST, glutathione S-transferase; IRbeta, IR beta subunit; ROS, rod outer segment(s); PI-4,5-P2, phosphatidylinositol-4,5-bisphosphate; Tr{alpha}, {alpha} subunit of transducin; RPE, retinal pigment epithelium; PTP1b, protein-tyrosine phosphatase 1b; WGA, wheat germ agglutinin. Back

3 R. V. S. Rajala, unpublished data. Back


   ACKNOWLEDGMENTS
 
We thank Dr. Michael Elliott for reading the manuscript and also for providing bovine rod outer segment plasma membrane and disks.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Barber, A. J., Nakamura, M., Wolpert, E. B., Reiter, C. E., Seigel, G. M., Antonetti, D. A., and Gardner, T. W. (2001) J. Biol. Chem. 276, 32814-32821[Abstract/Free Full Text]
  2. Yi, X., Schubert, M., Peachey, N. S., Suzuma, K., Burks, D. J., Kushner, J. A., Suzuma, I., Cahill, C., Flint, C. L., Dow, M. A., Leshan, R. L., King, G. L., and White, M. F. (2005) J. Neurosci. 25, 1240-1248[Abstract/Free Full Text]
  3. Li, G., Anderson, R. E., Tomita, H., Adler, R., Liu, X., Zack, D. J., and Rajala, R. V. (2007) J. Neurosci. 27, 203-211[Abstract/Free Full Text]
  4. Zheng, L., Anderson, R. E., Agbaga, M. P., Rucker, E. B., III, and Le, Y. Z. (2006) Invest. Ophthalmol. Vis. Sci. 47, 5583-5589[Abstract/Free Full Text]
  5. Alfinito, P. D., and Townes-Anderson, E. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 5655-5660[Abstract/Free Full Text]
  6. Cook, B., Lewis, G. P., Fisher, S. K., and Adler, R. (1995) Invest. Ophthalmol. Vis. Sci. 36, 990-996[Abstract/Free Full Text]
  7. Portera-Cailliau, C., Sung, C. H., Nathans, J., and Adler, R. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 974-978[Abstract/Free Full Text]
  8. Chinnaiyan, A. M., and Dixit, V. M. (1996) Curr. Biol. 6, 555-562[CrossRef][Medline] [Order article via Infotrieve]
  9. Strasser, A., O'Connor, L., and Dixit, V. M. (2000) Annu. Rev. Biochem. 69, 217-245[CrossRef][Medline] [Order article via Infotrieve]
  10. Datta, S. R., Ranger, A. M., Lin, M. Z., Sturgill, J. F., Ma, Y. C., Cowan, C. W., Dikkes, P., Korsmeyer, S. J., and Greenberg, M. E. (2002) Dev. Cell 3, 631-643[CrossRef][Medline] [Order article via Infotrieve]
  11. D'Mello, S. R., Borodezt, K., and Soltoff, S. P. (1997) J. Neurosci. 17, 1548-1560[Abstract/Free Full Text]
  12. Spear, N., Estevez, A. G., Barbeito, L., Beckman, J. S., and Johnson, G. V. (1997) J. Neurochem. 69, 53-59[Medline] [Order article via Infotrieve]
  13. Cantley, L. C. (2002) Science 296, 1655-1657[Abstract/Free Full Text]
  14. Schlessinger, J. (2000) Cell 103, 211-225[CrossRef][Medline] [Order article via Infotrieve]
  15. Song, J., Wu, L., Chen, Z., Kohanski, R. A., and Pick, L. (2003) Science 300, 502-505[Abstract/Free Full Text]
  16. Brogiolo, W., Stocker, H., Ikeya, T., Rintelen, F., Fernandez, R., and Hafen, E. (2001) Curr. Biol. 11, 213-221[CrossRef][Medline] [Order article via Infotrieve]
  17. Wolkow, C. A., Kimura, K. D., Lee, M. S., and Ruvkun, G. (2000) Science 290, 147-150[Abstract/Free Full Text]
  18. Steen, E., Terry, B. M., Rivera, E. J., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., and de la Monte, S. M. (2005) J. Alzheimer's Dis. 7, 63-80[Medline] [Order article via Infotrieve]
  19. de la Monte, S. M., and Wands, J. R. (2005) J. Alzheimer's Dis. 7, 45-61[Medline] [Order article via Infotrieve]
  20. de la Monte, S. M., and Wands, J. R. (2004) J. Alzheimer's Dis. 6, 231-242[Medline] [Order article via Infotrieve]
  21. Schubert, M., Gautam, D., Surjo, D., Ueki, K., Baudler, S., Schubert, D., Kondo, T., Alber, J., Galldiks, N., Kustermann, E., Arndt, S., Jacobs, A. H., Krone, W., Kahn, C. R., and Bruning, J. C. (2004) Proc. Natl. Acad. Sci. U. S. A. 101, 3100-3105[Abstract/Free Full Text]
  22. Rajala, R. V., McClellan, M. E., Ash, J. D., and Anderson, R. E. (2002) J. Biol. Chem. 277, 43319-43326[Abstract/Free Full Text]
  23. Rajala, R. V., and Anderson, R. E. (2003) Mol. Neurobiol. 28, 123-138[CrossRef][Medline] [Order article via Infotrieve]
  24. Calvert, P. D., Krasnoperova, N. V., Lyubarsky, A. L., Isayama, T., Nicolo, M., Kosaras, B., Wong, G., Gannon, K. S., Margolskee, R. F., Sidman, R. L., Pugh, E. N., Jr., Makino, C. L., and Lem, J. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 13913-13918[Abstract/Free Full Text]
  25. Lem, J., Krasnoperova, N. V., Calvert, P. D., Kosaras, B., Cameron, D. A., Nicolo, M., Makino, C. L., and Sidman, R. L. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 736-741[Abstract/Free Full Text]
  26. Redmond, T. M., Yu, S., Lee, E., Bok, D., Hamasaki, D., Chen, N., Goletz, P., Ma, J. X., Crouch, R. K., and Pfeifer, K. (1998) Nat. Genet. 20, 344-351[CrossRef][Medline] [Order article via Infotrieve]
  27. Kaplan, D. R., Whitman, M., Schaffhausen, B., Pallas, D. C., White, M., Cantley, L., and Roberts, T. M. (1987) Cell 50, 1021-1029[CrossRef][Medline] [Order article via Infotrieve]
  28. McGlade, C. J., Ellis, C., Reedijk, M., Anderson, D., Mbamalu, G., Reith, A. D., Panayotou, G., End, P., Bernstein, A., Kazlauskas, A., Waterfield, M. D., and Pawson, T. (1992) Mol. Cell Biol. 12, 991-997[Abstract/Free Full Text]
  29. Rajala, R. V., McClellan, M. E., Chan, M. D., Tsiokas, L., and Anderson, R. E. (2004) Biochemistry 43, 5637-5650[CrossRef][Medline] [Order article via Infotrieve]
  30. Smith, H. G., Jr., and Litman, B. J. (1982) Methods Enzymol. 81, 57-61[Medline] [Order article via Infotrieve]
  31. Papermaster, D. S. (1982) Methods Enzymol. 81, 48-52[Medline] [Order article via Infotrieve]
  32. Zimmerman, W. F., and Godchaux, W., III (1982) Methods Enzymol. 81, 52-57[Medline] [Order article via Infotrieve]
  33. Cuatrecasas, P., and Tell, G. P. (1973) Proc. Natl. Acad. Sci. U. S. A. 70, 485-489[Abstract/Free Full Text]
  34. Rajala, R. V., and Anderson, R. E. (2001) Invest. Ophthalmol. Vis. Sci. 42, 3110-3117[Abstract/Free Full Text]
  35. Ebina, Y., Ellis, L., Jarnagin, K., Edery, M., Graf, L., Clauser, E., Ou, J. H., Masiarz, F., Kan, Y. W., and Goldfine, I. D., Roth, R., and Rutter, W. J. (1985) Cell 40, 747-758[CrossRef][Medline] [Order article via Infotrieve]
  36. Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L. M., Dull, T. J., Gray, A., Coussens, L., Liao, Y. C., and Tsubokawa, M., Mason, A., Seeburg, P. H., Grunfeld, C., Rosen, O. M., and Ramachandran, J. (1985) Nature 313, 756-761[CrossRef][Medline] [Order article via Infotrieve]
  37. Jaissle, G. B., May, C. A., Reinhard, J., Kohler, K., Fauser, S., Lutjen-Drecoll, E., Zrenner, E., and Seeliger, M. W. (2001) Invest. Ophthalmol. Vis. Sci. 42, 506-513[Abstract/Free Full Text]
  38. Woodruff, M. L., Sampath, A. P., Matthews, H. R., Krasnoperova, N. V., Lem, J., and Fain, G. L. (2002) J. Physiol. 542, 843-854[Abstract/Free Full Text]
  39. Luttrell, L. M., van Biesen, T., Hawes, B. E., Koch, W. J., Krueger, K. M., Touhara, K., and Lefkowitz, R. J. (1997) Adv. Second Messenger Phosphoprotein Res. 31, 263-277[Medline] [Order article via Infotrieve]
  40. Luttrell, L. M., Daaka, Y., and Lefkowitz, R. J. (1999) Curr. Opin. Cell Biol. 11, 177-183[CrossRef][Medline] [Order article via Infotrieve]
  41. Lev, S., Hernandez, J., Martinez, R., Chen, A., Plowman, G., and Schlessinger, J. (1999) Mol. Cell Biol. 19, 2278-2288[Abstract/Free Full Text]
  42. Ghalayini, A. J., Guo, X. X., Koutz, C. A., and Anderson, R. E. (1998) Exp. Eye Res. 66, 817-821[CrossRef][Medline] [Order article via Infotrieve]
  43. Bell, M. W., Desai, N., Guo, X. X., and Ghalayini, A. J. (2000) J. Neurochem. 75, 2006-2019[CrossRef][Medline] [Order article via Infotrieve]
  44. Bell, M. W., Alvarez, K., and Ghalayini, A. J. (1999) J. Neurochem. 73, 2331-2340[CrossRef][Medline] [Order article via Infotrieve]
  45. Ghalayini, A. J., Desai, N., Smith, K. R., Holbrook, R. M., Elliott, M. H., and Kawakatsu, H. (2002) J. Biol. Chem. 277, 1469-1476[Abstract/Free Full Text]
  46. Hamada, J., Okumura, N., Inagaki, M., Taniguchi, H., Nakahata, Y., Sano, S., and Nagai, K. (2004) FEBS Lett. 557, 204-208[CrossRef][Medline] [Order article via Infotrieve]
  47. Chang, H. Y., and Ready, D. F. (2000) Science 290, 1978-1980[Abstract/Free Full Text]
  48. Balasubramanian, N., and Slepak, V. Z. (2003) Curr. Biol. 13, 1306-1310[CrossRef][Medline] [Order article via Infotrieve]
  49. Kasahara, T., Okano, T., Haga, T., and Fukada, Y. (2002) J. Neurosci. 22, 7321-7325[Abstract/Free Full Text]
  50. Arshavsky, V. Y. (2003) Sci. STKE 2003, E43
  51. Hardie, R. C. (2003) Curr. Biol. 13, R775-R777[CrossRef][Medline] [Order article via Infotrieve]
  52. Lee, S. J., Xu, H., Kang, L. W., Amzel, L. M., and Montell, C. (2003) Neuron 39, 121-132[CrossRef][Medline] [Order article via Infotrieve]
  53. Hong, D. H., Pawlyk, B., Sokolov, M., Strissel, K. J., Yang, J., Tulloch, B., Wright, A. F., Arshavsky, V. Y., and Li, T. (2003) Invest. Ophthalmol. Vis. Sci. 44, 2413-2421[Abstract/Free Full Text]
  54. Sokolov, M., Strissel, K. J., Leskov, I. B., Michaud, N. A., Govardovskii, V. I., and Arshavsky, V. Y. (2004) J. Biol. Chem. 279, 19149-19156[Abstract/Free Full Text]
  55. Sokolov, M., Lyubarsky, A. L., Strissel, K. J., Savchenko, A. B., Govardovskii, V. I., Pugh, E. N., Jr., and Arshavsky, V. Y. (2002) Neuron 34, 95-106[CrossRef][Medline] [Order article via Infotrieve]
  56. Strissel, K. J., Lishko, P. V., Trieu, L. H., Kennedy, M. J., Hurley, J. B., and Arshavsky, V. Y. (2005) J. Biol. Chem. 280, 29250-29255[Abstract/Free Full Text]
  57. Whelan, J. P., and McGinnis, J. F. (1988) J. Neurosci. Res. 20, 263-270[CrossRef][Medline] [Order article via Infotrieve]
  58. Broekhuyse, R. M., Tolhuizen, E. F., Janssen, A. P., and Winkens, H. J. (1985) Curr. Eye Res. 4, 613-618[Medline] [Order article via Infotrieve]
  59. Peng, Y. W., Rhee, S. G., Yu, W. P., Ho, Y. K., Schoen, T., Chader, G. J., and Yau, K. W. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 1995-2000[Abstract/Free Full Text]
  60. Reiter, C. E., Sandirasegarane, L., Wolpert, E. B., Klinger, M., Simpson, I. A., Barber, A. J., Antonetti, D. A., Kester, M., and Gardner, T. W. (2003) Am. J. Physiol. 285, E763-E774
  61. Reiter, C. E., Wu, X., Sandirasegarane, L., Nakamura, M., Gilbert, K. A., Singh, R. S., Fort, P. E., Antonetti, D. A., and Gardner, T. W. (2006) Diabetes 55, 1148-1156[Abstract/Free Full Text]
  62. Reiter, C. E., and Gardner, T. W. (2003) Prog. Retin. Eye Res. 22, 545-562[CrossRef][Medline] [Order article via Infotrieve]
  63. Rajala, R. V., and Chan, M. D. (2005) Biochemistry 44, 7929-7935[CrossRef][Medline] [Order article via Infotrieve]
  64. Rajala, R. V., Chan, M. D., and Rajala, A. (2005) Biochemistry 44, 15461-15471[CrossRef][Medline] [Order article via Infotrieve]
  65. Rajala, R. V., Tanito, M., Ma, J.-X., Lem, J., and Rajala, A. (2006) Invest. Ophthalmol. Vis. Sci. 47, 52 (Abstr. 1092)
  66. Bereziat, V., Kasus-Jacobi, A., Perdereau, D., Cariou, B., Girard, J., and Burnol, A. F. (2002) J. Biol. Chem. 277, 4845-4852[Abstract/Free Full Text]
  67. Cooney, G. J., Lyons, R. J., Crew, A. J., Jensen, T. E., Molero, J. C., Mitchell, C. J., Biden, T. J., Ormandy, C. J., James, D. E., and Daly, R. J. (2004) EMBO J. 23, 582-593[CrossRef][Medline] [Order article via Infotrieve]
  68. Nouaille, S., Blanquart, C., Zilberfarb, V., Boute, N., Perdereau, D., Roix, J., Burnol, A. F., and Issad, T. (2006) EMBO Rep. 7, 512-518[Medline] [Order article via Infotrieve]
  69. Nouaille, S., Blanquart, C., Zilberfarb, V., Boute, N., Perdereau, D., Burnol, A. F., and Issad, T. (2006) Biochem. Pharmacol. 72, 1355-1366[CrossRef][Medline] [Order article via Infotrieve]
  70. Yu, X., Rajala, R. V., McGinnis, J. F., Li, F., Anderson, R. E., Yan, X., Li, S., Elias, R. V., Knapp, R. R., Zhou, X., and Cao, W. (2004) J. Biol. Chem. 279, 13086-13094[Abstract/Free Full Text]
  71. Saltiel, A. R., and Pessin, J. E. (2002) Trends Cell Biol. 12, 65-71[CrossRef][Medline] [Order article via Infotrieve]
  72. Basinger, S., Hoffman, R., and Matthes, M. (1976) Science 194, 1074-1076[Abstract/Free Full Text]
  73. Hollyfield, J. G., and Rayborn, M. E. (1979) Invest. Ophthalmol. Vis. Sci. 18, 117-132[Abstract/Free Full Text]
  74. Fain, G. L., Matthews, H. R., Cornwall, M. C., and Koutalos, Y. (2001) Physiol. Rev. 81, 117-151[Abstract/Free Full Text]
  75. Penn, J. S., Naash, M. I., and Anderson, R. E. (1987) Exp. Eye Res. 44, 779-788[CrossRef][Medline] [Order article via Infotrieve]
  76. Organisciak, D. T., Xie, A., Wang, H. M., Jiang, Y. L., Darrow, R. M., and Donoso, L. A. (1991) Exp. Eye Res. 53, 773-779[CrossRef][Medline] [Order article via Infotrieve]
  77. Li, F., Cao, W., and Anderson, R. E. (2003) Invest. Ophthalmol. Vis. Sci. 44, 4968-4975[Abstract/Free Full Text]
  78. National Institutes of Health (1985) Guide for the Care Use of Laboratory Animals, National Institutes of Health, Bethesda, MD

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 IOVSHome page
A. K. Dilly and R. V. S. Rajala
Insulin Growth Factor 1 Receptor/PI3K/AKT Survival Pathway in Outer Segment Membranes of Rod Photoreceptors
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4765 - 4773.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Rajala, M. Tanito, Y. Z. Le, C. R. Kahn, and R. V. S. Rajala
Loss of Neuroprotective Survival Signal in Mice Lacking Insulin Receptor Gene in Rod Photoreceptor Cells
J. Biol. Chem., July 11, 2008; 283(28): 19781 - 19792.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/13/9865    most recent
M608845200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rajala, A.
Right arrow Articles by Rajala, R. V. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rajala, A.
Right arrow Articles by Rajala, R. V. S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement